Debbie Storms, LPN in Winner, SD - Licensed Practical Nurse

Debbie Storms, LPN is a Licensed Practical Nurse based in Winner, South Dakota. Debbie Storms is licensed to practice in South Dakota (license number SD-LPN P006924) and her current practice location is 500 E 9th St, Winner, South Dakota. She can be reached at her office (for appointments etc.) via phone at (605) 842-1465.

NPI number for Debbie Storms is 1316341019 and her current mailing address is 500 E 9th St, Winner, South Dakota. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1316341019.

Contact Information

	Debbie Storms, LPN
	500 E 9th St, Winner, SD 57580-2604
	(605) 842-1465
	(605) 842-2366

Provider's Profile

Full Name	Debbie Storms
Gender	Female
Speciality	Licensed Practical Nurse
Location	500 E 9th St, Winner, South Dakota
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1316341019
Provider Enumeration Date: 10/09/2014
Last Update Date: 10/09/2014

Medical Identifiers

Medical identifiers for Debbie Storms such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1316341019	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
164W00000X	Licensed Practical Nurse	SD-LPN P006924 (South Dakota)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Debbie Storms is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Debbie Storms, LPN 500 E 9th St, Winner, SD 57580-2604 Ph: (605) 842-1465	Debbie Storms, LPN 500 E 9th St, Winner, SD 57580-2604 Ph: (605) 842-1465

News Archive

Positive results from pacritinib Phase 3 trial for treatment of myelofibrosis presented at ASCO 2015

CTI BioPharma Corp. and Baxter International's Bioscience business today announced data from PERSIST-1 – a randomized Phase 3 registration-directed trial examining pacritinib for the treatment of myelofibrosis – in a late-breaking oral session at the 51st Annual Meeting of the American Society of Clinical Oncology, May 29-June 2, 2015 in Chicago, Ill.

Parents of new born convicted of reckless homicide

A newborn baby girl died unnecessarily because her parents rejected medical intervention for their ailing daughter.

MGH researchers identify protein that may protect tumor-initiating cells in breast cancer

Massachusetts General Hospital investigators have identified a protein that may play an essential role in maintaining a population of tumor-initiating cells (TICs) - treatment-resistant cells responsible for cancer recurrence and metastasis - in breast cancer, as well as a compound that appears to reduce the molecule's ability to protect TICs from the effects of chemotherapy.

Transgender men preserve their fertility potential after one year of testosterone therapy

Transgender men preserve their fertility potential even after one year of treatment with the male hormone testosterone, according to a study that will be presented Saturday at ENDO 2019, the Endocrine Society's annual meeting in New Orleans, La.

Debbie Storms, LPN - Licensed Practical Nurse in Winner, SD